1 |
Pakhomov S, Jacobsen SJ, Chute CG, Roger VL (2008). Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care 14, 530-9.
|
2 |
Palmer B, Walsh G, Mckinna J, Greening W (1980). Adjuvant chemotherapy for breast cancer: side effects and quality of life. BMJ, 281, 1594-7.
DOI
|
3 |
Royer HR, Phelan CH, Heidrich SM (2009). Older breast cancer survivors' symptom beliefs. Oncol nurs forum, 36, 463-70.
DOI
|
4 |
Russo F, Linsalata M, Clemente C, et al (2013). The effects of fluorouracil, epirubicin, and cyclophosphamide (fec60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. BMC Cancer, 13, 56.
DOI
|
5 |
Rustoen T (1995). Hope and quality of life, two central issues for cancer patients: a theoretical analysis. Cancer Nurs, 18, 355-61.
|
6 |
Scott N, Fayers P, Aaronson N, et al (2008). EORTC-QLQ-C30 reference values (2008). European organization for research and treatment of cancer, Brussels, Belgium.
|
7 |
Sharma R, Tobin P, Clarke SJ (2005). Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea. Lancet Oncol, 6, 93-102.
DOI
|
8 |
Singer P, Martin D, Kelner M (1999). Quality end-of-life care: patients' perspectives. JAMA, 281, 163-8.
DOI
|
9 |
Valderas JM, Kotzeva A, Espallargues M, et al (2008). The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res, 17, 179-93.
DOI
|
10 |
Watters JM, Yau JC, O'rourke K, et al (2003). Functional status is well maintained in older women during adjuvant chemotherapy for breast cancer. Ann Oncol, 14, 1744-1750.
DOI
|
11 |
Wolf I, Sadetzki S, Catane R, et al (2005). Diabetes mellitus and breast cancer. Lancet Oncol, 6, 103-11.
DOI
|
12 |
Dehkordi A, Heydarnejad MS, Fatehi D (2009). Quality of life in cancer patients undergoing chemotherapy. Oman Med J, 24, 204-7.
|
13 |
Aaronson NK, Ahmedzai S, Bergman B, et al (1993). The european organization for research and treatment of cancer qlq-c30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85, 365-76.
DOI
|
14 |
Akin S, Can G, Durna Z, Aydiner A (2008). The quality of life and self-efficacy of turkish breast cancer patients undergoing chemotherapy. Eur J Oncol Nurs, 12, 449-56.
DOI
|
15 |
Yusoff N, Low W, Yip C (2010). The malay version of the european organization forresearch and treatment of cancer quality of life questionnaire (eortc-qlq c30): reliability and validity study. Med J Malaysia, 9, 45-50.
|
16 |
Yusuf A, Abdul Hadi U, Mahamood Z, et al (2013). Quality of life in malay and chinese women newly diagnosed with breast cancer in kelantan, malaysia. Asian Pac J Cancer Prev, 14, 435-40.
DOI
|
17 |
Zainal AO, Nor Saleha IT (2011). The national cancer registry report. 2007. Ministry of health, Malaysia.
|
18 |
Cohen L, De Moor CA, Eisenberg P, et al (2007). Chemotherapyinduced nausea and vomiting-incidence and impact on patient quality of life at community oncology settings. Supp Care Cancer, 15, 497-503.
DOI
|
19 |
Cohn SH, Vartsky D, Yasumura S, et al (1980). Compartmental body composition based on total-body nitrogen, potassium, and calcium. Am J Physiol, 239, 524-30.
|
20 |
Desalvo KB, Bloser N, Reynolds K, et al (2006). Mortality prediction with a single general self-rated health question: a meta-analysis. J Gen Intern Med, 21, 267-75.
DOI
|
21 |
Eisenbraun J, Scheer R, Kroz M, et al (2011). Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract. Phytomedicine, 18, 151-7.
DOI
|
22 |
Bourdeanu L, Frankel P, Yu W, et al (2012). Chemotherapyinduced nausea and vomiting in asian women with breast cancer receiving anthracycline-based adjuvant chemotherapy. J Support Oncol, 10, 149-54.
DOI
|
23 |
Fayers PM, Aaronson NK, Bjordal K, et al (2001). Eortc QLQ-C30 scoring manual, european organisation for research and treatment of cancer. Cancer Invest, 19, 573-80.
DOI
|
24 |
Gozzo T, Moyses A, Silva P, Almeida A (2013). Nausea, vomiting and quality of life in women with breast cancer receiving chemotherapy. Rev Gaucha Enferm, 34, 110-6.
DOI
|
25 |
Helena M, Christina B, Bo N, Brandberg Y (2000). Healthrelated quality of life measured by the eortc qlq-c30: reference values from a large sample of the swedish population. Acta Oncologica, 39, 477-84.
DOI
|
26 |
Holzner B, Kemmler G, Kopp M, et al (2001). Quality of life in breast cancer patients-not enough attention for long-term survivors?. Psychosomatics, 42, 117-23.
DOI
|
27 |
Lua L, Zakaria NS, Mamat NM (2012). Health-related quality of life profile in relation to chemotherapy-induced nausea and vomiting among breast cancer patients. Asian J Psychiatr, 13.
|
28 |
Kadowaki S,Yamaguchi K (2011). Chemotherapyinduced stomatitis and diarrhea. Gan to kagaku ryoho. Cancer Chemother Pharmacol, 38, 1761-6.
|
29 |
Kallman D, Plato C, Tobin J (1990). The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. J Gerontol, 45, 82-8.
DOI
|
30 |
Keefe D, Brealey J, Goland G, Cummins A ( 2000). Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut, 47, 632-7.
DOI
|
31 |
Magaji BA, Moy FM, Roslani AC, et al (2012). Health-related quality of life among colorectal cancer patients in malaysia: a study protocol. BMC Cancer, 12, 384.
DOI
|
32 |
MOH, Malaysia (2011). Chemotherapy protocols systemic therapy of cancer. Department of Radiotherapy and Oncology/ Hospital Kuala Lumpur, Ministry of Health Malaysia. .
|
33 |
Melicher B & Zezulova M 2011. The significance of altered gastrointestinal permeability in cancer patients. Curr opin support palliat care, 5, 47-54.
DOI
|
34 |
Mols F, Vingerhoets AJ, Coebergh JW, Van De Poll-Franse LV (2005). Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer, 41, 2613-9.
DOI
|
35 |
Montazeri A, Vahdaninia M, Harirchi I, et al (2008). Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study. BMC Cancer, 8, 330.
DOI
|
36 |
Ogce F, Ozkan S (2008). Changes in functional status and physical and psychological symptoms in women receiving chemotherapy for breast cancer. Asian Pac J Cancer Prev, 9, 449-52.
|